Ori Biotech
Generated by Meeveem AI
"Automating cell and gene therapy manufacturing to accelerate patient access"
London
•51 - 250 Employees
•Medical Devices
About Ori Biotech
Ori Biotech develops IRO®, an advanced manufacturing platform that automates cell and gene therapy production without compromising biological performance. The platform addresses a critical challenge, more than 95% of eligible patients still lack access to life-saving therapies because they are complex, expensive, and difficult to manufacture at scale. IRO® combines a novel bioreactor with automated sterile connection technology to deliver superior biological results whilst accelerating development, reducing batch failures, and lowering costs. The platform supports seamless progression from research through to GMP production, enabling companies and academic institutions to scale therapies and make treatments more affordable and accessible.
88
Team Members
2015
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where every patient who needs a cell or gene therapy can access it, regardless of cost or location, because manufacturing is no longer a barrier to widespread availability.
Our Mission
Ori Biotech enables widespread patient access to life-saving cell and gene therapies through flexible manufacturing technology that streamlines development and accelerates commercialisation.